These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38246099)

  • 1. Herbal-based compounds: A review on treatments of cryptosporidiosis.
    Namazi F; Razavi SM
    Int J Parasitol Drugs Drug Resist; 2024 Apr; 24():100521. PubMed ID: 38246099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptosporidium and cryptosporidiosis.
    Soave R; Armstrong D
    Rev Infect Dis; 1986; 8(6):1012-23. PubMed ID: 3541121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is Cryptosporidium? Reappraising its biology and phylogenetic affinities.
    Barta JR; Thompson RC
    Trends Parasitol; 2006 Oct; 22(10):463-8. PubMed ID: 16904941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
    Nava MG; Calderón F; Fernández E; Ballell L; Bamborough P; Vinayak S
    Microbiol Spectr; 2023 Feb; 11(1):e0387422. PubMed ID: 36533912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in genetic manipulation of Cryptosporidium.
    Vinayak S
    Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice.
    Farid A; Yousry M; Safwat G
    J Ethnopharmacol; 2022 Jun; 292():115174. PubMed ID: 35259443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptosporidium spp. and cryptosporidiosis.
    Fayer R; Ungar BL
    Microbiol Rev; 1986 Dec; 50(4):458-83. PubMed ID: 3540573
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against
    Khan SM; Bajwa MR; Lahar RY; Witola WH
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056923. PubMed ID: 37655889
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryptosporidiosis and immune enteropathy: a review.
    Ma P
    Curr Clin Top Infect Dis; 1987; 8():99-153. PubMed ID: 3077284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research progress on nutrient transport and metabolism of Cryptosporidium].
    Wang JH; Xue XH; Li PY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Dec; 28(6):451-4. PubMed ID: 21500534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host cells with transient overexpression of MDR1 as a novel in vitro model for evaluating on-target effect for activity against the epicellular Cryptosporidium parasite.
    Yang B; Wang D; Liu M; Wu X; Yin J; Zhu G
    J Antimicrob Chemother; 2021 Dec; 77(1):124-134. PubMed ID: 34648615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptosporidium excystation and invasion: getting to the guts of the matter.
    Smith HV; Nichols RA; Grimason AM
    Trends Parasitol; 2005 Mar; 21(3):133-42. PubMed ID: 15734661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A "One-Health" Concern.
    Ali M; Xu C; Nawaz S; Ahmed AE; Hina Q; Li K
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic richness and diversity in Cryptosporidium hominis and C. parvum reveals major knowledge gaps and a need for the application of "next generation" technologies--research review.
    Jex AR; Gasser RB
    Biotechnol Adv; 2010; 28(1):17-26. PubMed ID: 19699288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target.
    Yang B; Yan Y; Wang D; Zhang Y; Yin J; Zhu G
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011217. PubMed ID: 36972284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidium: host and parasite transcriptome in infection.
    Relat RMB; O'Connor RM
    Curr Opin Microbiol; 2020 Dec; 58():138-145. PubMed ID: 33160225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.
    Manjunatha UH; Vinayak S; Zambriski JA; Chao AT; Sy T; Noble CG; Bonamy GMC; Kondreddi RR; Zou B; Gedeck P; Brooks CF; Herbert GT; Sateriale A; Tandel J; Noh S; Lakshminarayana SB; Lim SH; Goodman LB; Bodenreider C; Feng G; Zhang L; Blasco F; Wagner J; Leong FJ; Striepen B; Diagana TT
    Nature; 2017 Jun; 546(7658):376-380. PubMed ID: 28562588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.